
### [NCIT:C9331](http://purl.obolibrary.org/obo/NCIT_C9331)
**Label:** Malignant Gastric Neoplasm

**Subclasses:** [NCIT:C4911](http://purl.obolibrary.org/obo/NCIT_C4911) (Gastric Carcinoma), [NCIT:C4636](http://purl.obolibrary.org/obo/NCIT_C4636) (Gastric Lymphoma), [NCIT:C7788](http://purl.obolibrary.org/obo/NCIT_C7788) (Stage 0 Gastric Cancer AJCC v6 and v7), [NCIT:C5488](http://purl.obolibrary.org/obo/NCIT_C5488) (Gastric Liposarcoma), [NCIT:C27131](http://purl.obolibrary.org/obo/NCIT_C27131) (Early Gastric Cancer), [NCIT:C5248](http://purl.obolibrary.org/obo/NCIT_C5248) (Mucinous Gastric Adenocarcinoma), [NCIT:C5484](http://purl.obolibrary.org/obo/NCIT_C5484) (Malignant Gastric Granular Cell Tumor), [NCIT:C89859](http://purl.obolibrary.org/obo/NCIT_C89859) (Stage II Gastric Cancer AJCC v7), [NCIT:C5486](http://purl.obolibrary.org/obo/NCIT_C5486) (Malignant Gastric Germ Cell Tumor), [NCIT:C8399](http://purl.obolibrary.org/obo/NCIT_C8399) (Gastric Body Carcinoma), [NCIT:C4430](http://purl.obolibrary.org/obo/NCIT_C4430) (Gastric Body Carcinoma In Situ AJCC v6 and v7), [NCIT:C4431](http://purl.obolibrary.org/obo/NCIT_C4431) (Gastric Pylorus Carcinoma In Situ AJCC v6 and v7), [NCIT:C95749](http://purl.obolibrary.org/obo/NCIT_C95749) (Gastric Choriocarcinoma), [NCIT:C95903](http://purl.obolibrary.org/obo/NCIT_C95903) (Metastatic Malignant Neoplasm in the Stomach), [NCIT:C95748](http://purl.obolibrary.org/obo/NCIT_C95748) (Gastric Carcinoma with Lymphoid Stroma), [NCIT:C95747](http://purl.obolibrary.org/obo/NCIT_C95747) (Gastric Hepatoid Adenocarcinoma), [NCIT:C89856](http://purl.obolibrary.org/obo/NCIT_C89856) (Stage I Gastric Cancer AJCC v7), [NCIT:C91222](http://purl.obolibrary.org/obo/NCIT_C91222) (Gastric Cancer by AJCC v7 Stage), [NCIT:C95743](http://purl.obolibrary.org/obo/NCIT_C95743) (Poorly Cohesive Gastric Carcinoma), [NCIT:C5529](http://purl.obolibrary.org/obo/NCIT_C5529) (Gastric Kaposi Sarcoma), [NCIT:C27200](http://purl.obolibrary.org/obo/NCIT_C27200) (Gastric Leiomyosarcoma), [NCIT:C27763](http://purl.obolibrary.org/obo/NCIT_C27763) (Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C4004](http://purl.obolibrary.org/obo/NCIT_C4004) (Gastric Adenocarcinoma), [NCIT:C5253](http://purl.obolibrary.org/obo/NCIT_C5253) (Gastric Diffuse Large B-Cell Lymphoma), [NCIT:C5254](http://purl.obolibrary.org/obo/NCIT_C5254) (Gastric T-Cell Non-Hodgkin Lymphoma), [NCIT:C5256](http://purl.obolibrary.org/obo/NCIT_C5256) (Immature Gastric Teratoma), [NCIT:C8400](http://purl.obolibrary.org/obo/NCIT_C8400) (Gastric Antrum Carcinoma In Situ AJCC v6 and v7), [NCIT:C27765](http://purl.obolibrary.org/obo/NCIT_C27765) (Helicobacter Pylori-Related Gastric Adenocarcinoma), [NCIT:C5250](http://purl.obolibrary.org/obo/NCIT_C5250) (Signet Ring Cell Gastric Adenocarcinoma), [NCIT:C5251](http://purl.obolibrary.org/obo/NCIT_C5251) (Gastric Burkitt Lymphoma), [NCIT:C90503](http://purl.obolibrary.org/obo/NCIT_C90503) (Gastric Cancer by AJCC v6 Stage), [NCIT:C27235](http://purl.obolibrary.org/obo/NCIT_C27235) (Gastric Non-Hodgkin Lymphoma), [NCIT:C95884](http://purl.obolibrary.org/obo/NCIT_C95884) (Gastric Neuroendocrine Carcinoma), [NCIT:C95763](http://purl.obolibrary.org/obo/NCIT_C95763) (Gastric Intramucosal Adenocarcinoma), [NCIT:C27439](http://purl.obolibrary.org/obo/NCIT_C27439) (Malignant Gastric Soft Tissue Neoplasm), [NCIT:C5266](http://purl.obolibrary.org/obo/NCIT_C5266) (Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C6795](http://purl.obolibrary.org/obo/NCIT_C6795) (Gastric Pylorus Carcinoma), [NCIT:C67526](http://purl.obolibrary.org/obo/NCIT_C67526) (Gastric Mixed Adenocarcinoma), [NCIT:C43527](http://purl.obolibrary.org/obo/NCIT_C43527) (Sporadic Gastric Adenocarcinoma), [NCIT:C43529](http://purl.obolibrary.org/obo/NCIT_C43529) (Sporadic Diffuse Gastric Adenocarcinoma), [NCIT:C95886](http://purl.obolibrary.org/obo/NCIT_C95886) (Gastric Mixed Adenoneuroendocrine Carcinoma), [NCIT:C95885](http://purl.obolibrary.org/obo/NCIT_C95885) (Gastric Large Cell Neuroendocrine Carcinoma), [NCIT:C5638](http://purl.obolibrary.org/obo/NCIT_C5638) (Gastric Hodgkin Lymphoma), [NCIT:C6764](http://purl.obolibrary.org/obo/NCIT_C6764) (Gastric Small Cell Neuroendocrine Carcinoma), [NCIT:C43295](http://purl.obolibrary.org/obo/NCIT_C43295) (Hereditary Diffuse Gastric Adenocarcinoma), [NCIT:C9237](http://purl.obolibrary.org/obo/NCIT_C9237) (Recurrent Gastric Carcinoma), [NCIT:C5473](http://purl.obolibrary.org/obo/NCIT_C5473) (Gastric Tubular Adenocarcinoma), [NCIT:C7773](http://purl.obolibrary.org/obo/NCIT_C7773) (Stage II Gastric Cancer AJCC v6), [NCIT:C7772](http://purl.obolibrary.org/obo/NCIT_C7772) (Stage I Gastric Cancer AJCC v6), [NCIT:C5474](http://purl.obolibrary.org/obo/NCIT_C5474) (Gastric Adenosquamous Carcinoma), [NCIT:C5475](http://purl.obolibrary.org/obo/NCIT_C5475) (Gastric Squamous Cell Carcinoma), [NCIT:C9159](http://purl.obolibrary.org/obo/NCIT_C9159) (Diffuse Gastric Adenocarcinoma), [NCIT:C5476](http://purl.obolibrary.org/obo/NCIT_C5476) (Undifferentiated Gastric Carcinoma), [NCIT:C7774](http://purl.obolibrary.org/obo/NCIT_C7774) (Stage III Gastric Cancer AJCC v6), [NCIT:C9354](http://purl.obolibrary.org/obo/NCIT_C9354) (Recurrent Malignant Gastric Neoplasm), [NCIT:C9157](http://purl.obolibrary.org/obo/NCIT_C9157) (Gastric Intestinal-Type Adenocarcinoma), [NCIT:C9036](http://purl.obolibrary.org/obo/NCIT_C9036) (Stage IV Gastric Cancer AJCC v6), [NCIT:C5472](http://purl.obolibrary.org/obo/NCIT_C5472) (Gastric Papillary Adenocarcinoma), [NCIT:C89861](http://purl.obolibrary.org/obo/NCIT_C89861) (Stage IV Gastric Cancer AJCC v7), [NCIT:C89860](http://purl.obolibrary.org/obo/NCIT_C89860) (Stage III Gastric Cancer AJCC v7), [NCIT:C133638](http://purl.obolibrary.org/obo/NCIT_C133638) (Gastric Cancer by AJCC v8 Stage), [NCIT:C118813](http://purl.obolibrary.org/obo/NCIT_C118813) (Childhood Gastric Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36122](http://purl.obolibrary.org/obo/NCIT_C36122) (Benign Cellular Infiltrate) 75.00%
- Thing 51.13%
- [NCIT:C42077](http://purl.obolibrary.org/obo/NCIT_C42077) (Cellular Infiltrate) 36.79%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.24%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 27.58%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.37%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 26.79%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.52%
- CP:0000037 0.00%
- CP:0000035 0.00%
- CP:0000028 0.00%
- CP:0000027 0.00%
- CP:0000000 0.00%


